Cases & Deals

Baxter Ventures invests in VitalConnect

Clients Baxter Ventures

Jones Day represented Baxter Ventures in connection with its purchase of Series C Preferred Stock in a private placement by VitalConnect, a leader in medical-grade wearable biosensor systems. MVM Life Science Partners LLP acted as a co-investor.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.